In vitro metabolic interaction studies: experience of the Food and Drug Administration.

Abstract excerpt

A total of 194 new molecular entities approved by the Food and Drug Administration between 1992 and 1997 were surveyed to determine the role of in vitro metabolic interactions in the conduct of drug-drug interaction studies and to examine the methods used in these studies. Approximately 30% of the submissions were found to have in vitro metabolism-based interaction studies, most of which were inhibitory in...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cytochrome P-450 Enzyme Inhibitors
• Share to Drug Evaluation, Preclinical